POLY-HETEROARYL DERIVATIVES FOR THE TREATMENT OF CANCER
申请人:Nguyen Chi-hung
公开号:US20110201648A1
公开(公告)日:2011-08-18
The present invention relates to Penta-hexa-, hepta-, octa-, nona- and, deca-heteroaryl derivatives, comprising a combination of heterocycle 1 (Het-1)
a
and/or heterocycle 2 (Het-2)
b
and/or heterocycle 3 (Het-3)
c
and/or heterocycle 4 (Het-4)
d
of formulae I, II, III and IV respectively, the N-oxides, the pharmaceutically acceptable addition salts. The compounds claimed are suitable for the treatment of cancer.
[EN] POLY-HETEROARYL DERIVATIVES FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE POLY-HÉTÉROARYLE POUR LE TRAITEMENT DU CANCER